Gkb Ophthalmics Share PriceGKB Ophthalmics

₹99.00
-0.84 (-0.84%)
As on 27 September, 2023 | 10:53 BSE: 533212 NSE: GKBISIN: INE265D01015

Gkb Ophthalmics Performance

Day Range

  • Low 84
  • High 90.9
99.00

52 Week Range

  • Low 0
  • High 90.9
99.00
  • Open Price84.5
  • Previous Close88.4
  • Volume83081

Start SIP in GKB Ophthalmics

Start SIP

Gkb Ophthalmics Share Price

  • Over 1 Month 10.12%
  • Over 3 Month 6.74%
  • Over 6 Month -11.49%
  • Over 1 Year -8.63%

Gkb Ophthalmics Key Statistics

P/E Ratio -31.6
PEG Ratio 0.2
Market Cap Cr 50
Price to Book Ratio 0.7
EPS -5.8
Dividend 0
Relative Strength Index 55.63
Money Flow Index 80.91
MACD Signal 3.1
Average True Range 5.98

Gkb Ophthalmics Investment Rating

  • Master Rating:
  • Gkb Ophthalmics has an operating revenue of Rs. 79.90 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 0% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 9% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 11 which is a POOR score indicating inconsistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 108 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

GKB Ophthalmics Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1067787
Operating Expenses Qtr Cr 978777
Operating Profit Qtr Cr 1-1-1010
Depreciation Qtr Cr 120001
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr 0-20-10-1
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 3029
Operating Expenses Annual Cr 2927
Operating Profit Annual in Cr -10
Depreciation Cr 32
Interest Annual Cr 11
Tax Annual Cr 00
Net Profit Annual Cr -3-2
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -12
Cash from Investing Activity Annual Cr 2-1
Cash from Financing Annual Activity Cr -2-1
Net Cash Flow Annual Cr -10
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 2830
Fixed Assets Annual Cr 2125
Total Non Current Assets Annual Cr 3640
Total Current Assets Annual Cr 1314
Total Assets Annual Cr 4954
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 5560
ROE Annual % -10-8
ROCE Annual % -5-3
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 46
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 222019191817
Operating Expenses Qtr Cr 212019171516
Operating Profit Qtr Cr 100232
Depreciation Qtr Cr 120001
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr 1-2-1121
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 7672
Operating Expenses Annual Cr 7266
Operating Profit Annual in Cr 45
Depreciation Cr 33
Interest Annual Cr 21
Tax Annual Cr 00
Net Profit Annual Cr 01
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -35
Cash from Investing Activity Annual Cr 1-4
Cash from Financing Annual Activity Cr -2-2
Net Cash Flow Annual Cr -40
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 6363
Fixed Assets Annual Cr 2326
Total Non Current Assets Annual Cr 2935
Total Current Assets Annual Cr 8476
Total Assets Annual Cr 112110
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 134134
ROE Annual % 02
ROCE Annual % 35
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 68

Gkb Ophthalmics Technicals

EMA & SMA

Current Price
₹99.00
-0.84 (-0.84%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹98.05
  • 50 Day
  • ₹94.99
  • 100 Day
  • ₹97.22
  • 200 Day
  • ₹101.39
  • 20 Day
  • ₹98.01
  • 50 Day
  • ₹91.27
  • 100 Day
  • ₹94.88
  • 200 Day
  • ₹109.71

Gkb Ophthalmics Resistance and Support

PIVOT
₹99.6
Resistance
First Resistance ₹102.19
Second Resistance ₹104.54
Third Resistance ₹107.13
RSI 55.63
MFI 80.91
MACD Single Line 3.1
MACD 2.69
Support
First Resistance ₹97.25
Second Resistance ₹94.66
Third Resistance ₹92.31

Gkb Ophthalmics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,193 154,102 70.27
Week 2,259 165,201 73.13
1 Month 7,670 575,061 74.98
6 Month 6,982 534,391 76.54

Gkb Ophthalmics Result Highlights

GKB Ophthalmics Synopsis

BSE-Medical-Products

Gkb Ophthalmic is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company’s Total Operating Revenue is Rs. 27.73 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2023. GKB Ophthalmics Ltd. is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company’s Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469.
Market Cap 50
Sales 30
Shares in Float 0.21
No of funds 2
Yield
Book Value 1.83
U/D Vol ratio 1.9
LTDebt / Equity 4
Alpha 0.1
Beta 0.67

GKB Ophthalmics

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 59.18%59.09%59.09%59.16%
Foreign Portfolio Investors 1.79%1.79%1.98%1.98%
Individual Investors 27.39%27.11%24.8%24.82%
Others 11.64%12.01%14.13%14.04%

GKB Ophthalmics Management

Name Designation
Mr. K G Gupta Chairman & Managing Director
Mr. Vikram Gupta Director
Mr. Anil Palekar Director
Mr. Subhash Redkar Director
Mrs. Shashi Kumar Katreddi Director

Gkb Ophthalmics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Gkb Ophthalmics Corporate Action

Date Purpose Remarks
2023-08-11 Quarterly Results
2023-05-30 Audited Results
2023-02-14 Quarterly Results
2022-08-12 Quarterly Results
2022-05-30 Audited Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

GKB Ophthalmics FAQs

What is Share Price of GKB Ophthalmics ?

GKB Ophthalmics share price is ₹99 As on 27 September, 2023 | 10:39

What is the Market Cap of GKB Ophthalmics ?

The Market Cap of GKB Ophthalmics is ₹49.9 Cr As on 27 September, 2023 | 10:39

What is the P/E ratio of GKB Ophthalmics ?

The P/E ratio of GKB Ophthalmics is -31.6 As on 27 September, 2023 | 10:39

What is the PB ratio of GKB Ophthalmics ?

The PB ratio of GKB Ophthalmics is 0.7 As on 27 September, 2023 | 10:39

Q2FY23